Dividend on the way · $0.01
Embecta
Sells pen needles, syringes, and newer drug-delivery devices for diabetes and chronic care.
$5.01
After-hours close−0.04 (−0.79%)
At close$5.05(+1.61%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 86.97%51.60M sharesInsiders 3.64%2.16M sharesOther 9.39%5.57M shares
Shares outstanding 59.33M · Float 58.33M · 98.3% free float
Institutions13F, as of Jun 30, 2026
323 holders · 51.60M shares · 67 new positions · 145 increased · 75 reduced · 85 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 4.60M | 7.75% | −4.57M | Aug 7, 2026 |
| Yacktman Asset Management LP | 4.32M | 7.27% | +644.1K | Aug 11, 2026 |
| Vanguard Capital Management LLC | 2.56M | 4.31% | −6.8K | Aug 13, 2026 |
| Deerfield Management Company, L.P. (Series C) | 2.53M | 4.27% | 0 | Aug 14, 2026 |
| Jefferies Financial Group Inc. | 2.36M | 3.97% | −45 | Aug 17, 2026 |
| Ameriprise Financial Inc | 2.04M | 3.44% | +1.24M | Aug 14, 2026 |
| Morgan Stanley | 2.00M | 3.37% | +1.39M | Aug 13, 2026 |
| State Street Corp | 1.61M | 2.71% | −935.3K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.00% | 8.75M | 13G | Jul 18, 2025 ↗ |
| Yacktman Asset Management LPincl. Amg Yacktman Fund | 6.20% | 3.67M | 13G | May 5, 2026 ↗ |
| Stowers Institute for Medical Researchincl. American Century Investment Management, Inc., American Century Capital Portfolios, Inc. +1 more | 5.80% | 3.44M | 13G | May 1, 2026 ↗ |
| Vanguard Capital Management | 5.07% | 3.00M | 13G | Apr 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Devdatt Kurdikar | director, officer: President and CEO | 804.9K | 1.36% | Aug 13, 2026 |
| Jacob Elguicze | officer: SVP and CFO | 309.1K | 0.52% | Aug 13, 2026 |
| Jeffrey Z. Mann | officer: Pres, Pharm Svc&Prod Mgmt, CLO | 262.9K | 0.44% | Aug 13, 2026 |
| Robert J. Hombach | director | 109.6K | 0.18% | Aug 13, 2026 |
| Shaun Curtis | officer: SVP, Global Manuf./Sup. Chain | 95.3K | 0.16% | Dec 1, 2025 |
| David F. Melcher | director | 86.7K | 0.15% | May 23, 2025 |
| Jean Casner | officer: Chief Human Resources Officer | 85.9K | 0.14% | Aug 11, 2026 |
| Anthony M. Roth | officer: VP, Chief Accounting Officer | 78.8K | 0.13% | Jun 2, 2026 |
| Christopher R. Reidy | director | 70.1K | 0.12% | Feb 13, 2026 |
| Claire Pomeroy | director | 66.1K | 0.11% | Feb 13, 2026 |
3 people have not refiled in the last 18 months (89.2K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 12, 2026 | Jacob Elguiczeofficer: SVP and CFO | Purchase | 20,000 | $4.67 | 309,139 |
| Aug 12, 2026 | Devdatt Kurdikardirector, officer: President and CEO | Purchase | 30,000 | $4.70 | 804,919 |
| Aug 12, 2026 | Robert J. Hombachdirector | Purchase | 45,000 | $4.97 | 109,587 |
| Aug 12, 2026 | Jeffrey Z. Mannofficer: Pres, Pharm Svc&Prod Mgmt, CLO | Purchase | 20,000 | $4.99 | 262,915 |
CongressHouse and Senate disclosures
Not reported.